Atopic dermatitis (eczema) - topical steroids (TA81)
Fast, easy summary view of NICE guidance on 'atopic eczema in children'
NICE has made the following recommendations about the use of topical corticosteriods to treat atopic eczema within the NHS in England and Wales. The recommendations do not apply to topical steriod preparations that also contain other medicines, such as antibiotics.
NICE has recommended that corticosteriods should not be applied to the affected skin of people with atopic eczema more than twice a day.
NICE has recommended that if there is more than one type of topical corticosteroid that would be appropriate for a person's eczema, then the cheapest one should be used.
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: atopic eczema in children
This page was last updated: 28 August 2012
Information for the public
Implementation tools and resources
- None available
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.